Home › Bids
› Mood and Psychosis Symptoms during the Menopause Transition
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Open632 days leftHealthcaregrant
Nov 22, 2024
Jan 7, 2028 12:00 AM
Healthcare
grant
...
AI Summary
This grant opportunity, PAR-25-282, focuses on mood and psychosis symptoms during the menopause transition. It is an R21 Clinical Trial Optional grant, with CFDA numbers 93.242 and 93.313.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.